Quantcast

Tuberculosis Global Clinical Trials Review, H2, 2013

November 18, 2013

Reportbuyer.com just published a new market research report: Tuberculosis Global Clinical Trials Review, H2, 2013.

(PRWEB) November 18, 2013

Summary

GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H2, 2013" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Tuberculosis 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Tuberculosis 24

Subjects Recruited Over a Period of Time 28

Prominent Sponsors 29

Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30

Prominent Drug Comparison 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

GlaxoSmithKline plc 33

Clinical Trial Overview of GlaxoSmithKline plc 33

Pfizer Inc. 34

Clinical Trial Overview of Pfizer Inc. 34

Otsuka Pharmaceutical Co., Ltd. 35

Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 35

Janssen Infectious Diseases 36

Clinical Trial Overview of Janssen Infectious Diseases 36

Tibotec BVBA 37

Clinical Trial Overview of Tibotec BVBA 37

Alaeras, Inc 38

Clinical Trial Overview of Alaeras, Inc 38

Cadila Pharmaceuticals Ltd. 39

Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39

Vakzine Projekt Management GmbH 40

Clinical Trial Overview of Vakzine Projekt Management GmbH 40

Intercell AG 41

Clinical Trial Overview of Intercell AG 41

Johnson & Johnson 42

Clinical Trial Overview of Johnson & Johnson 42

Sequella, Inc. 43

Clinical Trial Overview of Sequella, Inc. 43

Sanofi 44

Clinical Trial Overview of Sanofi 44

AstraZeneca PLC 45

Clinical Trial Overview of AstraZeneca PLC 45

Silence Therapeutics plc 46

Clinical Trial Overview of Silence Therapeutics plc 46

Archivel Farma S.L. 47

Clinical Trial Overview of Archivel Farma S.L. 47

Otsuka Pharmaceutical Development & Commercialization, Inc. 48

Clinical Trial Overview of Otsuka Pharmaceutical Development & Commercialization, Inc. 48

AbbVie Inc. 49

Clinical Trial Overview of AbbVie Inc. 49

Interactive Research and Development 50

Clinical Trial Overview of Interactive Research and Development 50

World Health Advanced Technologies, Ltd. 51

Clinical Trial Overview of World Health Advanced Technologies, Ltd. 51

Clinical Trial Overview of Top Institutes / Government 52

The National Institute of Allergy and Infectious Diseases 52

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52

University of Oxford 56

Clinical Trial Overview of University of Oxford 56

U.S. Centers for Disease Control and Prevention 58

Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 58

University of Cape Town 60

Clinical Trial Overview of University of Cape Town 60

National Taiwan University Hospital 62

Clinical Trial Overview of National Taiwan University Hospital 62

National Heart, Lung, and Blood Institute 64

Clinical Trial Overview of National Heart, Lung, and Blood Institute 64

Statens Serum Institut 65

Clinical Trial Overview of Statens Serum Institut 65

Johns Hopkins University 66

Clinical Trial Overview of Johns Hopkins University 66

All India Institute of Medical Sciences 67

Clinical Trial Overview of All India Institute of Medical Sciences 67

Seoul National University Hospital 68

Clinical Trial Overview of Seoul National University Hospital 68

French National Agency for Research on AIDS and Viral Hepatitis 69

Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 69

London School of Hygiene & Tropical Medicine 70

Clinical Trial Overview of London School of Hygiene & Tropical Medicine 70

Department of Health, South Africa 71

Clinical Trial Overview of Department of Health, South Africa 71

Global Alliance for TB Drug Development 72

Clinical Trial Overview of Global Alliance for TB Drug Development 72

Tuberculosis Research Centre 73

Clinical Trial Overview of Tuberculosis Research Centre 73

Assistance Publique – Hopitaux de Paris 74

Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 74

Asan Medical Center 75

Clinical Trial Overview of Asan Medical Center 75

Aeras Global Tb Vaccine Foundation 76

Clinical Trial Overview of Aeras Global Tb Vaccine Foundation 76

University Medical Center Groningen 77

Clinical Trial Overview of University Medical Center Groningen 77

AIDS Clinical Trials Group 78

Clinical Trial Overview of AIDS Clinical Trials Group 78

Five Key Clinical Profiles 79

Appendix 111

Abbreviations 111

Definitions 111

Research Methodology 112

Secondary Research 112

About GlobalData 113

Contact Us 113

Disclaimer 113

Source 114

List of Tables

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8

Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11

Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12

Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2013* 13

Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14

Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15

Tuberculosis Therapeutics Clinical Trials, BRIC Countries, 2013* 16

Tuberculosis Therapeutics Clinical Trials, G7 Countries, 2013* 17

Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Tuberculosis Therapeutics Clinical Trials, E7 Countries, 2013* 19

Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21

Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22

Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Tuberculosis Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24

Tuberculosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25

Tuberculosis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26

Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28

Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29

Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31

Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 33

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 34

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 35

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Infectious Diseases, 2013* 36

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec BVBA, 2013* 37

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alaeras, Inc, 2013* 38

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2013* 39

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vakzine Projekt Management GmbH, 2013* 40

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 41

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 42

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2013* 43

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 44

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 45

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics plc, 2013* 46

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archivel Farma S.L., 2013* 47

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Development & Commercialization, Inc., 2013* 48

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 49

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Interactive Research and Development, 2013* 50

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by World Health Advanced Technologies, Ltd., 2013* 51

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 52

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 56

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 58

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2013* 60

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 62

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 64

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2013* 65

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 66

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2013* 67

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 68

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2013* 69

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 70

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2013* 71

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Global Alliance for TB Drug Development, 2013* 72

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuberculosis Research Centre, 2013* 73

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2013* 74

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 75

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeras Global Tb Vaccine Foundation, 2013* 76

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 77

Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2013* 78

List of Figures

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8

Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11

Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12

Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13

Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14

Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15

Tuberculosis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16

Tuberculosis Therapeutics Clinical Trials, G7 Countries (%), 2013* 17

Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Tuberculosis Therapeutics Clinical Trials, E7 Countries (%), 2013* 19

Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21

Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22

Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28

Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29

Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30

Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32

GlobalData Methodology 112

Read the full report:

Tuberculosis Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/tuberculosis_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11343483.htm


Source: prweb



comments powered by Disqus